We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
-6.81%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$118M
AUM Growth
-$23.8M
Cap. Flow
-$7.97M
Cap. Flow %
-6.74%
Top 10 Hldgs %
26.86%
Holding
154
New
13
Increased
16
Reduced
54
Closed
16

Top Sells

Rank Stock Value
1
FOCL
EDAP TMS S.A.
FOCL
+$3.01M
2
RMTI icon
Rockwell Medical
RMTI
+$1.37M
3
QUMU
Qumu Corp.
QUMU
+$1.37M
4
CNMD icon
CONMED
CNMD
+$1.14M
5
REI icon
Ring Energy
REI
+$1.06M

Sector Composition

Rank Sector Weight
1 Healthcare 40.02%
2 Technology 15.3%
3 Industrials 11.28%
4 Consumer Staples 4.34%
5 Consumer Discretionary 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMAT icon
26
LeMaitre Vascular
LMAT
$2.37B
$1.31M 1.11%
190,949
TULP
27
Bloomia Holdings
TULP
$16.1M
$1.31M 1.11%
60,910
+143
+0.2% +$3.07K
HPQ icon
28
HP
HPQ
$26B
$1.29M 1.09%
80,410
-771
-0.9% -$12.5K
ATRC icon
29
AtriCure
ATRC
$2.08B
$1.25M 1.05%
84,750
-45,900
-35% -$731K
ZIXI
30
DELISTED
Zix Corporation
ZIXI
$1.23M 1.04%
360,039
-48,677
-12% -$174K
TAP icon
31
Molson Coors Class B
TAP
$8.02B
$1.19M 1.01%
16,000
-4,900
-23% -$358K
HNSN
32
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$1.18M 1%
99,803
+133
+0.1% +$1.61K
PNR icon
33
Pentair
PNR
$10.8B
$1.17M 0.99%
26,678
UNH icon
34
UnitedHealth
UNH
$382B
$1.16M 0.98%
13,400
-200
-1% -$16.9K
CVS icon
35
CVS Health
CVS
$135B
$1.14M 0.96%
14,317
SQNM
36
DELISTED
SEQUENOM INC NEW
SQNM
$1.13M 0.95%
380,200
-41,000
-10% -$150K
MEET
37
DELISTED
The Meet Group, Inc. Common Stock
MEET
$1.13M 0.95%
+572,050
New +$1.3M
DTLK
38
DELISTED
Datalink Corp
DTLK
$1.11M 0.94%
104,875
-30,750
-23% -$345K
INWK
39
DELISTED
InnerWorkings, Inc.
INWK
$1.11M 0.94%
137,450
+109,950
+400% +$924K
IONS icon
40
Ionis Pharmaceuticals
IONS
$8.93B
$1.1M 0.93%
28,465
-2,500
-8% -$88.6K
SNY icon
41
Sanofi
SNY
$107B
$1.02M 0.86%
+18,050
New +$969K
VCEL icon
42
Vericel Corp
VCEL
$2.38B
$1M 0.85%
+352,000
New +$1.16M
ABBV icon
43
AbbVie
ABBV
$465B
$975K 0.82%
+16,875
New +$937K
APPS icon
44
Digital Turbine
APPS
$982M
$966K 0.82%
210,904
+52,904
+33% +$235K
JNJ icon
45
Johnson & Johnson
JNJ
$640B
$930K 0.79%
8,723
-150
-2% -$15.6K
DAKP
46
DELISTED
DAKOTA PLAINS HOLDINGS, INC. COMMON STOCK
DAKP
$918K 0.78%
+382,700
New +$921K
NTCT icon
47
NETSCOUT
NTCT
$2.83B
$916K 0.77%
20,000
-1,000
-5% -$44.8K
AXGN icon
48
Axogen
AXGN
$2.2B
$900K 0.76%
368,750
-6,000
-2% -$14.7K
CASC
49
DELISTED
Cascadian Therapeutics, Inc.
CASC
$892K 0.75%
77,450
-2,733
-3% -$41.7K
MDT icon
50
Medtronic
MDT
$112B
$886K 0.75%
14,300

Similar funds

Perkins Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Perkins Capital Management held 154 positions worth $118M, down 17% from $142M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Perkins Capital Management withdrew a net $7.97M in Q3 2014, closing 16 positions and reducing 54 holdings. Its most notable exit was EDAP TMS S.A., an estimated $3.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, Perkins Capital Management opened a new position in LiqTech worth $2.08M.

  • Perkins Capital Management's largest Q3 2014 buy was LiqTech: 42,133 shares worth $2.08M.
  • Perkins Capital Management added most to J.C. Penney Company, Inc. in Q3 2014, an estimated $1.32M increase.
  • Perkins Capital Management's biggest Q3 2014 reduction was Rockwell Medical, cutting an estimated $1.37M.
  • Perkins Capital Management fully exited EDAP TMS S.A. in Q3 2014, selling an estimated $3.01M.
  • Perkins Capital Management's ten largest holdings make up 27% of its $118M portfolio in Q3 2014.
  • Perkins Capital Management opened 13 new positions and closed 16 in Q3 2014.
  • Perkins Capital Management's portfolio value fell 17% quarter-over-quarter to $118M.

Based on Perkins Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.